Quantitative analysis of the ratios of the activated caspase-4 to the full-length caspase-4 or the loading control GAPDH on the same blots also confirmed the selective increase of activated caspase-4 in the ALS patient brains (Fig. 5b). This evidence concerns the gene CASP4 and amyotrophic lateral sclerosis.